RLAY
Relay Therapeutics, Inc. · Healthcare
CFO Thomas Catinazzo sold $120K of Relay Therapeutics, Inc.
Sold$119,631
$7.71Price
15,515Shares
−6%Stake
What RLAY did after the filing
- The stock from Fri, Jan 30 open, $7.70
- +31.6%
- S&P 500, same days
- −3.3%
Measured over 30 trading days, to the Mar 16 close.
Traded Tue, Jan 27. Filed Thu, Jan 29, 4:20 PM ET, after the close. Returns use the Jan 30 open and the Mar 16 close. Not investment advice.